[Updated May 12, 2024] When considering taking Zepbound for weight loss, it's essential to understand your insurance coverage and steps to getting coverage approval for your Zepbound prescription.
If you’re seeking honest insights and support in pursuit of Zepbound (GLP-1), you’ve come to the right place. In this guide, we’ll walk you through each step to determining whether Zepbound is covered by your insurance and how to get your Zepbound prescription covered by insurance. If your insurance has denied coverage for Zepbound, check out our 5 steps to appeal a Zepbound coverage denial.
Wherever you are in your GLP-1 weight loss journey - whether you’re new to GLP-1s, previously took or attempted to get a GLP-1, or are currently taking a GLP-1 and interested in switching to Zepbound - we have you covered. Feel free to skip to the sections of this guide that are most relevant to you.
Step 1: Understand your GLP-1 options
Step 2: Confirm you meet standard FDA requirements for Zepbound
Step 3: Review your insurance drug formulary policy for Zepbound
Step 4: Estimate your likelihood of receiving Zepbound coverage approval
Step 5: Decide on how you’ll get a Zepbound prescription
Step 6: Submit your personal evidence to your doctor and insurance
Step 7: If you are denied insurance coverage, submit an insurance appeal for Zepbound
Step 8: If you aren’t able to get Zepbound coverage, explore these alternative options
Key Takeaways
• While Zepbound has been demonstrated to be the most effective GLP-1 for weight loss, Wegovy and Saxenda are also effective options.
Zepbound is the most recent GLP-1 medication indicated for use in chronic weight management, and was approved by the FDA on Nov 8th, 2023. Zepbound is produced by Eli Lilly and contains the same active medication as Mounjaro - tirzepatide. In fact, the key difference between Zepbound and Mounjaro is that Zepbound is officially approved for weight management, while Mounjaro is approved by the FDA for Type 2 diabetes management.
While clinical trials have demonstrated Zepbound to be the most effective GLP-1 for weight-loss yet, it’s not your only option. Wegovy (semaglutide) and Saxenda (liraglutide) are two other GLP-1s approved by the FDA for weight loss. When deciding which GLP-1 is right for you, you want to consider your weight loss goals, insurance coverage, side effects and budget.
While Mounjaro and Ozempic are currently only approved by the FDA for treatment of Type 2 diabetes it doesn’t necessarily mean you won’t be able to access these medications. Off-label prescription of these medications for reducing the risks of developing type 2 diabetes or for treatment of metabolic syndrome have been successful for some but this depends highly on your insurance plan and clinical profile.
Key Takeaways
• FDA requirements are check by all insurance companies
• Zepbound is approved for adults with obesity (BMI ≥ 30) or a BMI over 27 who also have at least one weight-related medical condition.
• Honest Care’s rapid GLP-1 assessment can help you understand and document evidence of your eligibility your doctor and insurance
Zepbound, like Wegovy and Saxenda, is approved by the FDA for adults with obesity (BMI ≥ 30) or a BMI over 27 who also have at least one weight-related medical condition including:
Sharing detailed evidence demonstrating your basic eligibility will increase your chance of insurance coverage approval. This means sharing your diagnosis across all weight-related conditions (not just the ones list by the FDA), including the correct ICD-10 diagnosis code within your prescription, and sharing your most recent results from lab tests such as a Comprehensive Metabolic Panel (CMP), TSH, and HbA1c tests. Honest Care offers assistance in understanding and documenting your eligibility for Zepbound and other GLP-1s.
It’s also important to note that a personal or family history of certain medical conditions may exclude you from Zepbound coverage, or may be considered a precaution while on Zepbound**. These conditions include:
**We strongly encourage you to speak to your doctor if you have any questions regarding your medical eligibility for Zepbound, or if you have a history of any of these conditions.
Key Takeaways
• Medicare doesn’t cover currently cover Zepbound but will cover Wegovy to reduce the risk of heart attack and stroke.
• Commercial and private plans generally include at least partial coverage for at GLP-1s (Zepbound, Wegovy, Saxenda), but it’s critical to understand your plan’s unique policy
Insurance coverage is often the biggest hurdle to accessing a GLP-1, including Zepbound. To get coverage, it’s important to understand your insurance’s policies. Below are instructions on how.
Many commercial and private insurers cover weight loss medications like Zepbound, in part or in full. To find out if you plan covers Zepbound, you can try one of the following:
If you are told that insurance coverage includes a “plan exclusion” for weight loss medications, this means your employer chose not to cover weight loss medications as a category
ⓘ Make sure to use the Zepbound Savings Card if you have commercial insurance Learn more about saving on Zepbound
If you purchased insurance yourself through your state’s commercial exchange (e.g. Obamacare / Affordable Care Act), you can either call your insurance or check your insurance’s online portal (see instructions above).
Medicare’s official policy does not include coverage for Zepbound, Wegovy, Saxenda, or any other weight-loss medication. However, you may still be able to access a GLP-1 through an off-label prescription or other means. For example Medicare Part D plans do cover GLP-1s like Ozempic if prescribed for type 2 diabetes. In fact, Ozempic is one of the top 10 Medicare Part D drugs with total gross spending of $2.6 billion in 2021. Additionally as of March 8th, 2024 the FDA approved Wegovy (semaglutide) as a treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight which opens the door for prescriptions of Wegovy for patients with cardiovascular disease.
Coverage for Zepbound under Medicaid differs by state. You can refer to the Eli Lilly directory linked at the bottom of this page to explore your state’s Medicaid preferred medication list and check coverage specifics. If Zepbound isn't covered in your state, consider discussing an appeal with your healthcare provider. Interestingly, while most Medicaid programs typically exclude weight-loss medications, as of July 1, 2023, 16 states had coverage for at least one such medication:
If you're a government employee, coverage for Zepbound can vary greatly depending on your employment level—city, state, local municipality, or federal. For example the OPM requires every Federal Employees Health Benefits (FEHB) to cover at least one GLP-1 weight loss drug in 2025.
VA health care will cover obesity management, which means there is a decent chance that Zepbound is covered by your plan. To confirm, contact your local VA provider.
Key Takeaways
• Your next steps - and chances of approval - will depend on whether Zepbound is on your insurance plan’s formulary.
• Meeting the FDA’s eligibility requirements for Zepbound is only one criteria reviewed by insurance when determining coverage.
• Honest Care’s GLP-1 specialists can assist with understanding your likelihood of coverage and compiling evidence to help you get coverage.
Once you understand your insurance coverage benefits there are three general cases that have the most impact on your likelihood of getting approved by your insurance. Whether Zepbound is on your formulary (list of covered drugs) or is not on your formulary.
Zepbound is on your formulary
If Zepbound is present on your formulary, most insurance plans will likely require a prior authorization or other restrictions for GLP-1 medications before coverage will be approved.
Common clinical and process requirements include:
Zepbound is NOT on your formulary
If you find out that Zepbound is not a covered medication on your plan’s formulary, don’t panic, there are still options. Your next steps should be to confirm which of the following two categories you fall under to understand your coverage options.
Key Takeaways
• Working with your primary care physician (if you have one) can increase your chance of Zepbound approval
• Online, telehealth-based options can also be an option but you want to consider your budget first
If you’ve taken the above steps and think Zepbound is right for you, next you’ll want to decide what doctor you’ll work with to get a Zepbound prescription. Some considerations:
Key Takeaways
• Document your medical and weight history and submit it to you insurance to increase your chance of insurance coverage.
• Honest Care can generate evidence on your behalf through our rapid GLP-1 assessment and report
To increase your chance of accessing a prescription for Zepbound and getting coverage, do your best to compile documentation on your medical and weight history. Share this with your doctor when you discuss your prescription for Zepbound, and if you have a prescription written, ask your doctor to submit this documentation to your insurance to support your case. Some suggestions on what to include:
Key Takeaways
• If you’re denied Zepbound coverage, try appealing the decision with your insurance.
• Write a letter that addresses why Zepbound is right for you and submit it within your appeal.
• Let Honest Care write your appeal letter and gather supporting evidence so you can make your strongest case for insurance approval.
In the event that your insurance denies coverage for Zepbound, you can try appealing the decision. The insurance appeal process allows you to advocate with your insurance on why Zepbound is necessary for you. To appeal you’ll want to follow this high level process:
ⓘ Learn more about appeals? Read our 5 steps to appeal a Zepbound coverage denial.
If you aren’t able to get Zepbound covered by insurance, you still have options. Here are paths you can consider: